Results 71 to 80 of about 1,366 (180)

Generation of an induced pluripotent stem cell line (TRNDi002-B) from a patient carrying compound heterozygous p.Q208X and p.G310G mutations in the NGLY1 gene

open access: yesStem Cell Research, 2019
NGLY1 deficiency is a rare genetic disease caused by mutations in the NGLY1 gene that encodes N-glycanase 1. The disease phenotype in patient cells is unclear.
Rong Li   +11 more
doaj   +1 more source

Liver Involvement in Congenital Disorders of Glycosylation and Deglycosylation

open access: yesFrontiers in Pediatrics, 2021
Background: Congenital disorders of glycosylation (CDG) and NGLY1-CDDG (NGLY1-congenital disorder of deglycosylation) usually represent multisystem (especially neurovisceral) diseases with liver involvement reported in some of them.
Patryk Lipiński   +3 more
doaj   +1 more source

A conserved role for AMP-activated protein kinase in NGLY1 deficiency.

open access: yesPLoS Genetics, 2020
Mutations in human N-glycanase 1 (NGLY1) cause the first known congenital disorder of deglycosylation (CDDG). Patients with this rare disease, which is also known as NGLY1 deficiency, exhibit global developmental delay and other phenotypes including ...
Seung Yeop Han   +6 more
doaj   +1 more source

The Biochemical Basis of Congenital Disorders of Glycosylation [PDF]

open access: yes, 2018
The enzyme peptide: N-glycanase (EC 3.5.1.52) is an endoglycosidase which cleaves N-linked glycans from incorrectly folded glycoproteins exported from the endoplasmic reticulum during ER-associated degradation (ERAD).
Needs, Sarah
core   +1 more source

Two novel compound heterozygous mutations in NGLY1as a cause of congenital disorder of deglycosylation: a case presentation

open access: yesBMC Medical Genetics, 2020
Background NGLY1-related congenital disorder of deglycosylation (NGLY1-CDDG) is a multisystemic neurodevelopmental disorder in which affected individuals show developmental delay, epilepsy, intellectual disability, abnormal liver function, and poor ...
Haixia Ge   +6 more
doaj   +1 more source

NGLY1 mutation causes neuromotor impairment, intellectual disability, and neuropathy [PDF]

open access: yesEuropean Journal of Medical Genetics, 2015
N-glycanase 1 (NGLY1) is a conserved enzyme that is responsible for the deglycosylation of misfolded N-glycosylated proteins in the cytoplasm prior to their proteasome-mediated degradation. Disruption of this degradation process has been associated with various neurologic diseases including amyotrophic lateral sclerosis and Parkinson's disease.
Caglayan, Ahmet Okay   +14 more
openaire   +4 more sources

Neurodegeneration, cell signaling and neuroreparative strategies, Volume II [PDF]

open access: yes, 2023
Funding Information: This work was partly supported by the grant UID/DTP/04138/2019-22 (iMed.ULisboa) as well as La Caixa Foundation and Francisco Luzón Foundation through project HR21-00931. VP acknowledges financial support from the Spanish Ministry of
Falcão, Ana Sofia   +2 more
core   +1 more source

Defects in the Neuroendocrine Axis Contribute to Global Development Delay in a Drosophila Model of NGLY1 Deficiency

open access: yesG3: Genes, Genomes, Genetics, 2018
N-glycanase 1 (NGLY1) Deficiency is a rare monogenic multi-system disorder first described in 2014. NGLY1 is evolutionarily conserved in model organisms.
Tamy Portillo Rodriguez   +5 more
doaj   +1 more source

Cytosolic O-GlcNAcylation and PNG1 maintain Drosophila gut homeostasis by regulating proliferation and apoptosis.

open access: yesPLoS Genetics, 2022
Tissue homeostasis requires a delicate balance between stem cell self-renewal, proliferation, and differentiation. Essential to this process is glycosylation, with both intra-and extra-cellular glycosylation being required for stem cell homeostasis ...
Hyun-Jin Na   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy